MedTrace Logo

microRNAs Role in Pre-eclampsia Diagnosis

NCT03562715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-06-19

No results posted yet for this study

Summary

Pre-eclampsia is one of the most threatening pregnancy complications. So far neither a secure, competent therapy for PE nor effective biomarkers for a premature discovery has been achieved.The aim of our study was to identify miRNAs 136, 494 and 495 genes expression in exosomes of peripheral blood compared to umbilical cord mesenchymal stem cells conditioned media released exososomes in patients with PE, as valuable markers for PE early prediction.

Conditions

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
23 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-28
Primary Completion
2017-06-15
Completion
2017-12-25

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03562715 on ClinicalTrials.gov